{
    "nctId": "NCT03471741",
    "briefTitle": "Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer",
    "officialTitle": "Moderated Accelerated RAdiotherapy (MARA-2) in Moderate-high Risk Breast Cancer: a Phase I-II Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Radiation Toxicity",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 451,
    "primaryOutcomeMeasure": "Incidence of treatment.related late adverse events",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* histologically confirmed invasive breast cancer (pT1-4) with at least one of these characteristics: 3 or more metastatic axillary nodes, pre or peri-menopausal status, close resection margins\n* breast conservative surgery\n\nExclusion Criteria:\n\n* positive margins\n* distant metastases",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}